Surface proteomics reveals CD72 as a target for in vitro-evolved nanobody-based CAR-T cells in refractory B-cell malignancies I
Ontology highlight
ABSTRACT: Surface proteomics reveals CD72 as a target for in vitro-evolved nanobody-based CAR-T cells in refractory B-cell malignancies I
PROVIDER: PRJNA597032 | ENA |
REPOSITORIES: ENA
ACCESS DATA